SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-23-000036
Filing Date
2023-05-15
Accepted
2023-05-15 06:51:30
Documents
75
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20230331x10q.htm   iXBRL 10-Q 2961216
2 EX-10.3 alim-20230331xex10_3.htm EX-10.3 931228
3 EX-10.4 alim-20230331xex10_4.htm EX-10.4 55571
4 EX-31.1 alim-20230331xex31_1.htm EX-31.1 21005
5 EX-31.2 alim-20230331xex31_2.htm EX-31.2 21318
6 EX-32.1 alim-20230331xex32_1.htm EX-32.1 16291
  Complete submission text file 0001267602-23-000036.txt   12309146

Data Files

Seq Description Document Type Size
7 EX-101.SCH alim-20230331.xsd EX-101.SCH 53339
8 EX-101.CAL alim-20230331_cal.xml EX-101.CAL 63109
9 EX-101.DEF alim-20230331_def.xml EX-101.DEF 206612
10 EX-101.LAB alim-20230331_lab.xml EX-101.LAB 531869
11 EX-101.PRE alim-20230331_pre.xml EX-101.PRE 382296
69 EXTRACTED XBRL INSTANCE DOCUMENT alim-20230331x10q_htm.xml XML 2514307
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 23918300
SIC: 2834 Pharmaceutical Preparations